Cargando…
Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation
BACKGROUND: Sepsis is a leading cause of death in intensive care units (ICUs), but outcomes of individual patients are difficult to predict. The recently developed clinical metabolomics has been recognized as a promising tool in the clinical practice of critical illness. The objective of this study...
Autores principales: | Wang, Jing, Sun, Yizhu, Teng, Shengnan, Li, Kefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157979/ https://www.ncbi.nlm.nih.gov/pubmed/32290837 http://dx.doi.org/10.1186/s12916-020-01546-5 |
Ejemplares similares
-
Microbial metabolites in the blood of patients with sepsis
por: Khodakova, Anastasia, et al.
Publicado: (2007) -
Death to sepsis: targeting apoptosis pathways in sepsis
por: Wheeler, Derek S
Publicado: (2009) -
Combining Blood-Based Biomarkers to Predict Mortality of Sepsis at Arrival at the Emergency Department
por: Xie, Yinjing, et al.
Publicado: (2021) -
Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room
por: Kauppi, Anna M., et al.
Publicado: (2016) -
Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death
por: Santisukwongchote, Kobchai, et al.
Publicado: (2019)